AG
SPPI

Aperio Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Aperio Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$493K Sell
144,688
-6,964
-5% -$28.7K ﹤0.01% 1976
2020
Q3 		$619K Buy
151,652
+51,155
+51% +$194K ﹤0.01% 1698
2020
Q2 		$340K Buy
100,497
+87,007
+645% +$254K ﹤0.01% 1968
2020
Q1 		$31K Sell
13,490
-2,182
-14% -$5.97K ﹤0.01% 2293
2019
Q4 		$57K Sell
15,672
-12,236
-44% -$98.9K ﹤0.01% 2293
2019
Q3 		$231K Buy
27,908
+14,874
+114% +$120K ﹤0.01% 2128
2019
Q2 		$112K Buy
13,034
+464
+4% +$4.15K ﹤0.01% 2354
2019
Q1 		$134K Buy
+12,570
New +$135K ﹤0.01% 2217
2016
Q4 		– Sell
-13,353
Closed -$62K – 2141
2016
Q3 		$62K Sell
13,353
-13,796
-51% -$81.7K ﹤0.01% 2037
2016
Q2 		$178K Buy
27,149
+939
+4% +$6.63K ﹤0.01% 1894
2016
Q1 		$167K Buy
26,210
+14,966
+133% +$76.8K ﹤0.01% 1904
2015
Q4 		$68K Buy
+11,244
New +$64.3K ﹤0.01% 1945

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aperio Group's SPPI Position: Q4 2020 in Review

Aperio Group reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 4.6% in Q4 2020, selling an estimated $28.7K and leaving 144,688 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Aperio Group first reported a position in SPPI in Q4 2015 and has held it in 12 quarters since. The position peaked at $619K in Q3 2020. 161 funds tracked by Wall St. Rank hold SPPI as of Q4 2020.

  • Aperio Group held 144,688 shares of Spectrum Pharmaceuticals Inc worth $493K as of Q4 2020.
  • Aperio Group sold 6,964 Spectrum Pharmaceuticals Inc shares in Q4 2020, an estimated $28.7K.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1976 holding.
  • Aperio Group first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and has held it in 12 quarters since.
  • Aperio Group's Spectrum Pharmaceuticals Inc position peaked at $619K in Q3 2020.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.